| ASSET | YEARS | % RETURN |
|---|---|---|
QXO (QXO) | 2010-2023 | 28,508,425% |
Altimmune (ALT) | 2010-2023 | 5,624,900% |
Avita Medical (RCEL) | 2010-2023 | 3,429,900% |
Lunai Bioworks (LNAI) | 2010-2023 | 2,697,772.34% |
Mesoblast (MESO) | 2010-2023 | 2,199,900% |
Lexaria Bioscience (LEXX) | 2010-2023 | 1,102,841.18% |
Nocera (NCRA) | 2010-2023 | 659,900% |
MDxHealth (MDXH) | 2010-2023 | 656,566.67% |
Fubotv (FUBO) | 2010-2023 | 635,900% |
CleanSpark (CLSK) | 2010-2023 | 551,400% |
Akari Therapeutics (AKTX) | 2010-2023 | 499,100% |
Addex Therapeutics (ADXN) | 2010-2023 | 336,011.11% |
Evogene (EVGN) | 2010-2023 | 335,900% |
LiveOne (LVO) | 2010-2023 | 277,900% |
Agape ATP Corporation Common Stock (ATPC) | 2010-2023 | 212,900% |
Integra Resources (ITRG) | 2010-2023 | 211,900% |
Immatics (IMTX) | 2010-2023 | 210,500% |
Xpel (XPEL) | 2010-2023 | 141,610.53% |
Lottery (SEGG) | 2010-2023 | 136,080.9% |
FingerMotion (FNGR) | 2010-2023 | 129,577.42% |
A2Z Smart Technologies (AZ) | 2010-2023 | 92,467.57% |
authID (AUID) | 2010-2023 | 75,580% |
Addentax (ATXG) | 2010-2023 | 61,614.29% |
Beeline (BLNE) | 2010-2023 | 38,638.74% |
BioLife Solutions (BLFS) | 2010-2023 | 27,028.55% |